Arsenic trioxide-induced cytotoxicity in A549 cells: The role of necroptosis

 

 Buy Article Permissions and Reprints

Abstract

Introduction Lung cancer is one of the deadliest cancers globally. Arsenic trioxide (ATO) is still present as a highly effective drug in treating acute promyelocytic leukemia (APL). Chemotherapy resistance is one of the major problems in cancer therapy. Necroptosis, can overcomes resistance to apoptosis, and can promote cancer treatment. This study examines the necroptosis pathway in A549 cancer cells exposed to ATO.

Methods We used the MTT test to determine the ATO effects on the viability of A549 cells at three different time intervals. Also, the reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were performed in three-time intervals. The effect of ATO on apoptosis was evaluated by Annexin V / PI staining and, the RIPK1 and MLKL gene expression were measured by Real-Time PCR.

Results The ATO has dose and time-dependent cytotoxic effects, so at 24, 48, and 72 h, the IC50 doses were 33.81 ‘11.44 ‘2.535 µM respectively. A 50 μM ATO is the most appropriate to increase the MMP loss significantly at all three times. At 24 and 48 h after exposure of cells to ATO, the ROS levels increased. The RIPK1 gene expression increased significantly compared to the control group at concentrations of 50 and 100 μM; however, MLKL gene expression decreased.

Conclusions The A549 cells, after 48 h exposure to ATO at 50 and 100 μM, induces apoptosis and necroptosis. Due to the reduced expression of MLKL, it can be concluded that ATO is probably effective in the metastatic stage of cancer cells.

^* both authors contributed equally to this work: Maryam Jamil, Afshin Mohammadi-Bardbori

Publication History

Received: 14 February 2023

Accepted: 11 April 2023

Article published online:
25 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Walker AM, Stevens JJ, Ndebele K, Tchounwou PB.. Evaluation of arsenic trioxide potential for lung cancer treatment: assessment of apoptotic mechanisms and oxidative damage. J Cancer Sci Ther 2016; 8: 1-9
  CrossrefPubMedGoogle Scholar
• 2 Minna JD, Roth JA, Gazdar AF.. Focus on lung cancer. Cancer cell 2002; 1: 49-52
  CrossrefPubMedGoogle Scholar
• 3 de Groot PM, Wu CC, Carter BW, Munden RF.. The epidemiology of lung cancer. Transl Lung Cancer Res 2018; 7: 220-233
  CrossrefPubMedGoogle Scholar
• 4 Park HK, Han BR, Park WH.. Combination of arsenic trioxide and valproic acid efficiently inhibits growth of lung cancer cells via G2/M-phase arrest and apoptotic cell death. Int J Mol Sci 2020; 21: 2649
  CrossrefPubMedGoogle Scholar
• 5 Yang M-H, Chang K-J, Li B, Chen W-S.. Arsenic trioxide suppresses tumor growth through antiangiogenesis via notch signaling blockade in small-cell lung cancer. Biomed Res Int 2019; 2019: 4647252
  PubMedGoogle Scholar
• 6 Huang W, Zeng Y.. A candidate for lung cancer treatment: arsenic trioxide. Clin Transl Oncol 2019; 21: 1115-1126
  CrossrefPubMedGoogle Scholar
• 7 D’Arcy MS.. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 2019; 43: 582-592
  CrossrefPubMedGoogle Scholar
• 8 Momtaz S, Salek-Maghsoudi A, Abdolghaffari A.H, Jasemi E, Rezazadeh S, Hassani S, Ziaee M, Abdollahi M, Behzad S. S-M Nabavi. Polyphenols targeting diabetes via the AMP-activated protein kinase pathway; future approach to drug discovery. Crit Rev Clin Lab Sci 2019; 56: 472-492
  CrossrefPubMedGoogle Scholar
• 9 Khamseh ME, Sheikhi A, Shahsavari Z, Ghorbani M, Akbari H, Imani M, Panahi M, Alimohammadi A, Ameri M, Nazem S, Salimi V, Tavakoli-Yaraki M.. Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas. BMC Endocr Disord 2022; 22: 1-11
  CrossrefPubMedGoogle Scholar
• 10 Choi ME, Price DR, Ryter SW, Choi AM.. Necroptosis: a crucial pathogenic mediator of human disease. JCI insight 2019; 4: e128834
  CrossrefPubMedGoogle Scholar
• 11 Xia X, Lei L, Wang S, Hu J, Zhang G.. Necroptosis and its role in infectious diseases. Apoptosis 2020; 25: 169-178
  CrossrefPubMedGoogle Scholar
• 12 Dhuriya YK, Sharma D.. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation 2018; 15: 1-9
  CrossrefPubMedGoogle Scholar
• 13 Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X, Li Q, Zheng X, Saxton B, Chen W, Willink R, Li Z, Zhang L, Belinsky SA, Wang X, Zhou B, Lin Y.. Epigenetic regulation of RIP3 suppresses necroptosis and increases resistance to chemotherapy in nonsmall cell lung cancer. Transl Oncol 2020; 13: 372-382
  CrossrefPubMedGoogle Scholar
• 14 Mosmann T.. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
  CrossrefPubMedGoogle Scholar
• 15 Mohammadi-Bardbori A, Omidi M, Arabnezhad M-R.. Impact of CH223191-induced mitochondrial dysfunction on its aryl hydrocarbon receptor agonistic and antagonistic activities. Chem Res Toxicol 2019; 32: 691-697
  CrossrefPubMedGoogle Scholar
• 16 Park WH.. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress. Oncol Rep 2020; 43: 358-367
  PubMedGoogle Scholar
• 17 You BR, Kim SH, Park WH.. Reactive oxygen species, glutathione, and thioredoxin influence suberoyl bishydroxamic acid-induced apoptosis in A549 lung cancer cells. Tumor Biol 2015; 36: 3429-3439
  CrossrefPubMedGoogle Scholar
• 18 Lim MC, Maubach G, Sokolova O, Feige MH, Diezko R, Buchbinder J, Backert S, Schlüter D, Lavrik IN, Naumann M.. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-κB and caspase-8-dependent apoptotic cell death. Cell Death Differ 2017; 24: 1621-1631
  CrossrefPubMedGoogle Scholar
• 19 Yi J, Yang J, He R, Gao F, Sang H, Tang X, Ye RD.. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res 2004; 64: 108-116
  CrossrefPubMedGoogle Scholar
• 20 Kang YH, Lee SJ.. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. J Cell Physiol 2008; 217: 23-33
  CrossrefPubMedGoogle Scholar
• 21 Hosseini A, Abdollahi M, Hassanzadeh G, Rezayat M, Hassani S, Pourkhalili N, Tabrizian K, Khorshidahmad T, Beyer C, Sharifzadeh M.. Protective effect of magnesium-25 carrying porphyrin-fullerene nanoparticles on the degeneration of dorsal root ganglion neurons and motor function in experimental diabetic neuropathy. Basic Clin Pharmacol Toxicol 2011; 109: 381-386
  CrossrefPubMedGoogle Scholar
• 22 Marshall KD, Baines CP.. Necroptosis: is there a role for mitochondria?. Front Physiol 2014; 5: 323
  CrossrefPubMedGoogle Scholar
• 23 Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH.. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Biochem Pharmacol 2006; 72: 1228-1236
  CrossrefPubMedGoogle Scholar
• 24 Jiang X, Chen C, Zhao W, Zhang Z.. Sodium arsenite and arsenic trioxide differently affect the oxidative stress, genotoxicity and apoptosis in A549 cells: an implication for the paradoxical mechanism. Environ Toxicol Pharmacol 2013; 36: 891-902
  CrossrefPubMedGoogle Scholar
• 25 Han YH, Kim SZ, Kim SH, Park WH.. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine. Mol Cells 2008; 26: 158-164
  PubMedGoogle Scholar
• 26 Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types. Int J Mol Med 2010; 25: 121-128
  PubMedGoogle Scholar
• 27 Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G.. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY) 2016; 8: 603-19
  CrossrefPubMedGoogle Scholar
• 28 Kweon M-H, Adhami VM, Lee J-S, Mukhtar H.. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 2006; 281: 33761-33772
  CrossrefPubMedGoogle Scholar
• 29 Zhou C, Zhu Y, Lu B, Zhao W, Zhao X.. Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine. Oncol Lett 2018; 16: 5466-5472
  PubMedGoogle Scholar
• 30 Liu H, Su Q, Wu Q, Fang W, Yang D, Zheng W, Wang X.. FTIR spectroscopic study on apoptosis of lung cancer cell line A549 induced by arsenic trioxide. Infrared Phys Technol 2018; 93: 340-345
  CrossrefPubMedGoogle Scholar
• 31 Zhu F, Zhang W, Yang T, He SD.. Complex roles of necroptosis in cancer. J Zhejiang Univ Sci B 2019; 20: 399-413
  CrossrefPubMedGoogle Scholar
• 32 Della Torre L, Nebbioso A, Stunnenberg HG, Martens JH, Carafa V, Altucci L.. The role of necroptosis: Biological relevance and its involvement in cancer. Cancers 2021; 13: 684
  CrossrefPubMedGoogle Scholar
• 33 Wang Q, Chen W, Xu X, Li B, He W, Padilla MT, Jang JH, Nyunoya T, Amin S, Wang X, Lin Y.. RIP1 potentiates BPDE-induced transformation in human bronchial epithelial cells through catalase-mediated suppression of excessive reactive oxygen species. Carcinogenesis 2013; 34: 2119-2128
  CrossrefPubMedGoogle Scholar
• 34 Park JE, Lee JH, Lee SY, Hong MJ, Choi JE, Park S, Jeong JY, Lee EB, Choi SH, Lee YH, Seo HW, Yoo SS, Lee J, Cha SI, Kim CH, Park JY.. Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer. J Cancer 2020; 11: 5503
  CrossrefPubMedGoogle Scholar
• 35 Hu B, Shi D, Lv X, Chen S, Huang Q, Xie M, Shao Z.. Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis. BMC cancer 2018; 18: 1-10.
  PubMedGoogle Scholar
• 36 Jing L, Song F, Liu Z, Li J, Wu B, Fu Z, Jiang J, Chen Z.. MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Lett 2018; 414: 136-146
  CrossrefPubMedGoogle Scholar
• 37 Ma YM, Peng YM, Zhu QH, Gao AH, Chao B, He QJ, Li J, Hu YH, Zhou YB.. Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-κB inhibition. Acta Pharmacol Sin 2016; 37: 1381-1390
  CrossrefPubMedGoogle Scholar
• 38 Lin C-Y, Tam LyM, Yang SH, Lai S-C, Chang T-W, Lin I-H, Tzeng Y-J., Tanshinone IIA. Shows Higher Antiproliferative Activities than Sinapic Acid in 4 Cancer Cell Lines and Simultaneously Induces Apoptosis and Necroptosis in Human Lung Cancer A549 Cells. Nat Prod Commun 2021; 16 1934578X211050521
  PubMedGoogle Scholar
• 39 Su Z, Yang Z, Xu Y, Chen Y, Yu Q.. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol cancer 2015; 14: 1-14
  PubMedGoogle Scholar